Few Hemodialysis Patients on Medicare Enroll in Hospice

Share this content:
Few Hemodialysis Patients on Medicare Enroll in Hospice
Few Hemodialysis Patients on Medicare Enroll in Hospice

WEDNESDAY, June 27, 2018 (HealthDay News) -- Among Medicare beneficiaries on hemodialysis, few patients are enrolled in hospice at the end of life, regardless of the spending trajectory during the last year of life, according to a study published in the June issue of Health Affairs.

Ann M. O'Hare, M.D., from the University of Washington in Seattle, and colleagues examined hospice use and timing in a national cohort of Medicare beneficiaries on hemodialysis with distinct spending trajectories during their last year of life.

The researchers identified four distinct spending trajectories, which represented different intensities of care. Within the cohort, 9, 13, 41, and 37 percent had escalated spending, persistently high spending, relatively low spending with late escalation, and moderate spending with late escalation. The percentages of patients enrolled in hospice at the time of death were universally low across the groups, varying from 19 to 21 percent of those with persistently high costs and moderate costs, respectively. The median number of days spent in hospice during the last year of life was almost the same (five or six days) across the groups.

"These findings likely reflect the impact of policy and perhaps other barriers to the receipt of hospice care for patients on hemodialysis and signal the need for more flexible approaches to the provision of end-of-life care for members of this population," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: U.S. Abortion Rate Declined 24 Percent From 2006 to 2015

CDC: U.S. Abortion Rate Declined 24 Percent From ...

Abortions among women ages 15-44 fell 26 percent, from 15.9 to 11.8 abortions per 1,000 women

U of Maryland Student Dies of Adenovirus-Related Illness

U of Maryland Student Dies of Adenovirus-Related Illness

CDC testing of specimen revealed adenovirus type 7, a strain that may cause more severe illness

FDA Approves Drug to Treat Rare Immune Disease

FDA Approves Drug to Treat Rare Immune Disease

Gamifant first drug to be approved specifically for primary hemophagocytic lymphohistiocytosis

is free, fast, and customized just for you!




Already a member?

Sign In Now »